Top Buy
| Security | Buy | Sell | Buy (1W) ▼ | Sell (1W) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| GSK plc ADR | 4 | 0 | 0 | 0 | €42.00 | - | - |
| G1 Therapeutics | 15 | 1 | 0 | 0 | €4.44 | €10.56 | 137.922% |
| MPH Health Care AG | 1 | 0 | 0 | 0 | €25.00 | - | - |
| Innoviva Inc. | 3 | 0 | 0 | 0 | €14.20 | €30.00 | 111.268% |
| Akero Therapeutics Inc | 12 | 0 | 0 | 0 | €19.44 | €38.19 | 96.469% |
| Novo Nordisk A/S ADR | 17 | 1 | 0 | 0 | €119.50 | €130.44 | 9.153% |
| Twist Bioscience Corp | 7 | 0 | 0 | 0 | €39.34 | €41.41 | 5.259% |
| Cocrystal Pharma Inc. | 6 | 0 | 0 | 0 | €1.60 | €10.08 | 529.875% |
| Blueprint Medicines Corp | 2 | 0 | 0 | 0 | €99.02 | - | - |
| Sensorion SA | 2 | 0 | 0 | 0 | €0.69 | - | - |
| Virbac S.A. | 1 | 0 | 0 | 0 | €352.00 | - | - |
| Vericel Corp. | 1 | 0 | 0 | 0 | €44.80 | - | - |
| Vanda Pharmaceuticals | 4 | 0 | 0 | 0 | €4.68 | €5.00 | 6.838% |
| ImmunityBio Inc. | 3 | 0 | 0 | 0 | €7.52 | €10.00 | 32.908% |
| Icon plc | 18 | 0 | 0 | 0 | €292.80 | €319.67 | 9.177% |
| Viracta Therapeutics Inc. | 1 | 0 | 0 | 0 | €0.72 | - | - |
| Cellectar BioSciences Inc. | 7 | 8 | 0 | 0 | €2.86 | €10.55 | 268.734% |
| Gilead Sciences Inc | 12 | 1 | 0 | 0 | €61.21 | €86.77 | 41.760% |
| Lisata Therapeutics Inc. | 1 | 0 | 0 | 0 | €2.54 | €4.00 | 57.480% |
| Corbus Pharmaceuticals Holding Inc. | 2 | 1 | 0 | 0 | €39.40 | €50.00 | 26.904% |
| Chimerix Inc. | 4 | 1 | 0 | 0 | €0.90 | €5.51 | 515.469% |
| Deciphera Pharmaceuticals | 6 | 0 | 0 | 0 | €23.20 | €21.66 | -6.642% |
| QIAGEN NV | 9 | 0 | 0 | 0 | €40.47 | €47.44 | 17.223% |
| Laboratorios Farmaceuticos | 1 | 0 | 0 | 0 | €83.65 | €100.00 | 19.546% |
| Heidelberg Pharma AG | 3 | 0 | 0 | 0 | €3.00 | - | - |